The whole archive, filed by the part of life it belongs to — and labelled with how strong the evidence behind it actually is.
Showing 2401–2424 of 3,535
A recent study has demonstrated that a **12-week intervention combining Tai Chi with elastic band training** significantly enhances physical mobility and execut...
Pliant Therapeutics has reported promising results from its Phase 1 trial of **PLN-101095** in combination with **pembrolizumab** for patients with **immune che...
Theriva Biologics has announced promising results from the Phase 2b VIRAGE clinical trial evaluating **VCN-01** (zabilugene almadenorepvec) in combination with...
A recent study from the University of Sydney's Charles Perkins Centre has revealed that increasing daily step counts can significantly mitigate the health risks...
Matthew Lang has transitioned from his role at Metsera to become the chief operating officer and general counsel at Structure Therapeutics. His move follows his...
Engineers at **Northwestern University** have developed **printed artificial neurons** capable of direct communication with living brain cells, marking a signif...
A recent study from the USC Norris Comprehensive Cancer Center reveals a troubling association between a **healthy diet**—characterized by high consumption of f...
Boundless Bio has unveiled promising preclinical data for its lead ecDNA-directed therapy, **BBI-940**, at the AACR Annual Meeting 2026. This innovative treatme...
**Theriva Biologics** is set to present pivotal findings from the **VIRAGE Phase 2b clinical trial** at the upcoming **AACR Annual Meeting** in San Diego, highl...
Cardiff Oncology, Inc. has unveiled promising preclinical data at the AACR Annual Meeting 2026, showcasing the efficacy of its oral **PLK1 inhibitor, onvanserti...
Olema Pharmaceuticals has confirmed the **mechanism of action** for its complete estrogen receptor antagonist (CERAN) palazestrant, which effectively recruits t...
Xilio Therapeutics has unveiled promising preclinical data for **XTX601**, a masked T cell engager specifically targeting **claudin 18.2 (CLDN18.2)**, at the AA...
**JimStoppani.com** has launched its **Summer Shred Challenge**, a fitness competition aimed at enhancing participants' strength, endurance, and body compositio...
The National Institute on Aging's **Interventions Testing Program (ITP)** has recently assessed eleven compounds for their potential to extend lifespan in genet...
**Opticore Eye Group** has announced the launch of its **innovative Contact Lens Program** in Riverside, California, set to begin in 2026. This initiative aims...
Recent data from Spherix Global Insights’ Launch Dynamix™ service highlights a significant uptick in the adoption of **rebalancing agents** for hemophilia treat...
The **global pacemakers market** is projected to escalate from **$5.4 billion in 2024 to $7.5 billion by 2030**, reflecting a **compound annual growth rate (CAG...
Researchers at Rockefeller University have developed a groundbreaking approach to enhance immune responses by genetically engineering **hematopoietic stem and p...
Seragon Biosciences has unveiled promising preclinical results for its investigational longevity drug, **SRN-901**, which demonstrates a **33% increase in media...
Avaí Bio, a microcap biotech firm based in Vilnius, is pioneering a novel approach to longevity by targeting the **α-Klotho protein**, which diminishes with age...
Helical has secured **$10 million in seed funding** to develop an innovative "virtual AI lab" aimed at transforming drug discovery processes for pharmaceutical...
Global Widget, LLC, a prominent U.S.-based contract manufacturer specializing in gummy supplements, marks its 10-year anniversary, reflecting a decade of rapid...
Rubedo Life Sciences has achieved a significant milestone with **RLS-1496**, the first GPX4 modulator to enter human clinical trials, demonstrating promising pr...
Wilcrest Pharmaceuticals, Inc. has secured a national group purchasing agreement for Outsourced Compounded Preparations with Premier, Inc., effective April 1, 2...
